ATNM
Price
$1.69
Change
+$0.04 (+2.42%)
Updated
Aug 15 closing price
Capitalization
51.47M
100 days until earnings call
CRSP
Price
$59.73
Change
+$0.89 (+1.51%)
Updated
Aug 15 closing price
Capitalization
5.35B
74 days until earnings call
Interact to see
Advertisement

ATNM vs CRSP

Header iconATNM vs CRSP Comparison
Open Charts ATNM vs CRSPBanner chart's image
Actinium Pharmaceuticals
Price$1.69
Change+$0.04 (+2.42%)
Volume$103.74K
Capitalization51.47M
CRISPR Therapeutics AG
Price$59.73
Change+$0.89 (+1.51%)
Volume$3.06M
Capitalization5.35B
ATNM vs CRSP Comparison Chart in %
Loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNM vs. CRSP commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Hold and CRSP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (ATNM: $1.65 vs. CRSP: $58.82)
Brand notoriety: ATNM and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 29% vs. CRSP: 136%
Market capitalization -- ATNM: $51.47M vs. CRSP: $5.35B
ATNM [@Biotechnology] is valued at $51.47M. CRSP’s [@Biotechnology] market capitalization is $5.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.07B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATNM and CRSP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 5 TA indicator(s) are bullish while CRSP’s TA Score has 5 bullish TA indicator(s).

  • ATNM’s TA Score: 5 bullish, 5 bearish.
  • CRSP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than ATNM.

Price Growth

ATNM (@Biotechnology) experienced а +5.77% price change this week, while CRSP (@Biotechnology) price change was +5.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.94%. For the same industry, the average monthly price growth was +21.39%, and the average quarterly price growth was +21.23%.

Reported Earning Dates

ATNM is expected to report earnings on Nov 24, 2025.

CRSP is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+5.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($5.35B) has a higher market cap than ATNM($51.5M). CRSP YTD gains are higher at: 49.441 vs. ATNM (30.952). ATNM has higher annual earnings (EBITDA): -48.36M vs. CRSP (-455.24M). CRSP has more cash in the bank: 1.86B vs. ATNM (65.3M). ATNM has less debt than CRSP: ATNM (1.43M) vs CRSP (219M). CRSP has higher revenues than ATNM: CRSP (35M) vs ATNM (0).
ATNMCRSPATNM / CRSP
Capitalization51.5M5.35B1%
EBITDA-48.36M-455.24M11%
Gain YTD30.95249.44163%
P/E RatioN/AN/A-
Revenue035M-
Total Cash65.3M1.86B4%
Total Debt1.43M219M1%
FUNDAMENTALS RATINGS
ATNM vs CRSP: Fundamental Ratings
ATNM
CRSP
OUTLOOK RATING
1..100
7477
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9995
PRICE GROWTH RATING
1..100
5042
P/E GROWTH RATING
1..100
10080
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRSP's Valuation (67) in the Biotechnology industry is in the same range as ATNM (73). This means that CRSP’s stock grew similarly to ATNM’s over the last 12 months.

CRSP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATNM (100). This means that CRSP’s stock grew similarly to ATNM’s over the last 12 months.

CRSP's SMR Rating (95) in the Biotechnology industry is in the same range as ATNM (99). This means that CRSP’s stock grew similarly to ATNM’s over the last 12 months.

CRSP's Price Growth Rating (42) in the Biotechnology industry is in the same range as ATNM (50). This means that CRSP’s stock grew similarly to ATNM’s over the last 12 months.

CRSP's P/E Growth Rating (80) in the Biotechnology industry is in the same range as ATNM (100). This means that CRSP’s stock grew similarly to ATNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNMCRSP
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 9 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SFSLX26.410.04
+0.15%
1919 Financial Services C
IIIIX13.36-0.01
-0.07%
Voya International Index Port I
MBINX31.63-0.08
-0.25%
NYLI Balanced Investor Class
THVRX31.02-0.11
-0.35%
Thornburg International Equity R4
VSCPX341.45-4.23
-1.22%
Vanguard Small Cap Index InstlPlus

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with IPSC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
+3.12%
IPSC - ATNM
49%
Loosely correlated
+3.15%
CRBU - ATNM
43%
Loosely correlated
+2.56%
RXRX - ATNM
43%
Loosely correlated
-1.05%
ABOS - ATNM
40%
Loosely correlated
+10.24%
CRSP - ATNM
40%
Loosely correlated
+2.60%
More